Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04432727 · ClinicalTrials.gov registry record · NA
Study Evaluating Flexitouch Plus With Connectivity on Compliance in 30 Patients With Breast Cancer-Related Lymphedema.
A NA study, sponsored by Tactile Medical.
- Completed
- Registry status
- NA
- Development phase
- 29
- Enrollment target
NCT04432727 is a NA study that has completed, run by Tactile Medical. The registered enrollment target is 29 participants.
The verdict
NCT04432727, a NA study, has completed, sponsored by Tactile Medical.
- COMPLETED
- Registry status
- NA
- Development phase
- 29 participants
- Enrollment target
Study Summary
The objective of this study is to demonstrate the feasibility of using the Flexitouch Plus with Cellular Connectivity (FT-CC) to monitor device use data to determine if reminders to patients impact compliance, and to identify the impact device compliance has on arm girth, quality of life (QOL), and symptom assessment.
Interventions
- DEVICE Flexitouch Plus with Cellular Connectivity (FT-CC)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 29 participants |
| Start Date | 2020-08-13 |
| Est. Completion | 2021-11-19 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04432727
The ClinicalTrials.gov registry entry for NCT04432727 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 29 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Tactile Medical, which has 14 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Flexitouch Plus with Cellular Connectivity (FT-CC) is the first listed.
NCT04432727 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04432727 about?
NCT04432727 is a clinical study titled "Study Evaluating Flexitouch Plus With Connectivity on Compliance in 30 Patients With Breast Cancer-Related Lymphedema.". The objective of this study is to demonstrate the feasibility of using the Flexitouch Plus with Cellular Connectivity (FT-CC) to monitor device use data to determine if reminders to patients impact compliance, and to identify the impact device compliance has on arm girth, quality of life (QOL), and ...
What is the current status of trial NCT04432727?
This trial is currently completed. It is a NA study. The enrollment target is 29 participants. The study started on 2020-08-13. Estimated completion is 2021-11-19.
What interventions are being tested in trial NCT04432727?
The interventions under investigation include: Flexitouch Plus with Cellular Connectivity (FT-CC) (DEVICE).
Who is sponsoring clinical trial NCT04432727?
This trial is sponsored by Tactile Medical, which has 14 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.